Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

122 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Canadian framework for managing prostate cancer during the COVID-19 pandemic: Recommendations from the Canadian Urologic Oncology Group and the Canadian Urological Association.
Kokorovic A, So AI, Hotte SJ, Black PC, Danielson B, Emmenegger U, Finelli A, Niazi T, Pouliot F, Shayegan B, Sridhar S, Vigneault E, Loblaw A, Rendon RA. Kokorovic A, et al. Among authors: vigneault e. Can Urol Assoc J. 2020 Jun;14(6):163-168. doi: 10.5489/cuaj.6667. Can Urol Assoc J. 2020. PMID: 32374715 Free PMC article. No abstract available.
Testosterone recovery after androgen deprivation therapy in localised prostate cancer: Long-term data from two randomised trials.
Nabid A, Carrier N, Vigneault E, Martin AG, Bahary JP, Van Nguyen T, Vavassis P, Vass S, Brassard MA, Bahoric B, Archambault R, Vincent F, Bettahar R, Duclos M, Wilke D, Souhami L. Nabid A, et al. Among authors: vigneault e. Radiother Oncol. 2024 Jun;195:110256. doi: 10.1016/j.radonc.2024.110256. Epub 2024 Mar 27. Radiother Oncol. 2024. PMID: 38552845 Clinical Trial.
Canadian prostate brachytherapy in 2012.
Keyes M, Crook J, Morris WJ, Morton G, Pickles T, Usmani N, Vigneault E. Keyes M, et al. Among authors: vigneault e. Can Urol Assoc J. 2013 Jan-Feb;7(1-2):51-8. doi: 10.5489/cuaj.218. Can Urol Assoc J. 2013. PMID: 23671495 Free PMC article.
Stereotactic Ablative Radiotherapy Versus Low Dose Rate Brachytherapy or External Beam Radiotherapy: Propensity Score Matched Analyses of Canadian Data.
Loblaw A, Pickles T, Crook J, Martin AG, Vigneault E, Souhami L, Cury F, Morris J, Catton C, Lukka H, Cheung P, Sethukavalan P, Warner A, Yang Y, Rodrigues G; Genitourinary Radiation Oncologists of Canada (GUROC). Loblaw A, et al. Among authors: vigneault e. Clin Oncol (R Coll Radiol). 2017 Mar;29(3):161-170. doi: 10.1016/j.clon.2016.10.001. Epub 2016 Oct 22. Clin Oncol (R Coll Radiol). 2017. PMID: 27780694
Randomised Phase II Feasibility Trial of Image-guided External Beam Radiotherapy With or Without High Dose Rate Brachytherapy Boost in Men with Intermediate-risk Prostate Cancer (CCTG PR15/ NCT01982786).
Vigneault E, Morton G, Parulekar WR, Niazi TM, Springer CW, Barkati M, Chung P, Koll W, Kamran A, Monreal M, Ding K, Loblaw A. Vigneault E, et al. Clin Oncol (R Coll Radiol). 2018 Sep;30(9):527-533. doi: 10.1016/j.clon.2018.05.007. Epub 2018 Jun 11. Clin Oncol (R Coll Radiol). 2018. PMID: 29903505 Clinical Trial.
Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer.
Davis ID, Martin AJ, Stockler MR, Begbie S, Chi KN, Chowdhury S, Coskinas X, Frydenberg M, Hague WE, Horvath LG, Joshua AM, Lawrence NJ, Marx G, McCaffrey J, McDermott R, McJannett M, North SA, Parnis F, Parulekar W, Pook DW, Reaume MN, Sandhu SK, Tan A, Tan TH, Thomson A, Tu E, Vera-Badillo F, Williams SG, Yip S, Zhang AY, Zielinski RR, Sweeney CJ; ENZAMET Trial Investigators and the Australian and New Zealand Urogenital and Prostate Cancer Trials Group. Davis ID, et al. N Engl J Med. 2019 Jul 11;381(2):121-131. doi: 10.1056/NEJMoa1903835. Epub 2019 Jun 2. N Engl J Med. 2019. PMID: 31157964 Clinical Trial.
122 results